These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 26345256)

  • 21. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
    Cai Y; Yoneda M; Tomita T; Kurotani R; Okamoto M; Kido T; Abe H; Mitzner W; Guha A; Kimura S
    BMC Pulm Med; 2015 Jul; 15():72. PubMed ID: 26178733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mouse model of paraquat-poisoned lungs and its gene expression profile.
    Tomita M; Okuyama T; Katsuyama H; Miura Y; Nishimura Y; Hidaka K; Otsuki T; Ishikawa T
    Toxicology; 2007 Mar; 231(2-3):200-9. PubMed ID: 17215068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annexin A5 promotes macrophage activation and contributes to pulmonary fibrosis induced by silica particles.
    Luo C; Ji X; Fan J; Hou Z; Wang T; Wu B; Ni C
    Toxicol Ind Health; 2016 Sep; 32(9):1628-38. PubMed ID: 25757482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of SOD3 in silica-related lung fibrosis and pulmonary vascular remodeling.
    Zelko IN; Zhu J; Roman J
    Respir Res; 2018 Nov; 19(1):221. PubMed ID: 30453980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis.
    Kato S; Inui N; Hakamata A; Suzuki Y; Enomoto N; Fujisawa T; Nakamura Y; Watanabe H; Suda T
    Respir Res; 2018 Jun; 19(1):127. PubMed ID: 29940932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice.
    Langenbach SY; Wheaton BJ; Fernandes DJ; Jones C; Sutherland TE; Wraith BC; Harris T; Schuliga MJ; McLean C; Stewart AG
    Can J Physiol Pharmacol; 2007 Jul; 85(7):727-38. PubMed ID: 17823636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-resolved proteome and transcriptome of paraquat-induced pulmonary fibrosis.
    Fan L; Li Y; Zhang X; Wu Y; Song Y; Zhang F; Zhang J; Sun H
    Pulm Pharmacol Ther; 2022 Aug; 75():102145. PubMed ID: 35817254
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis.
    Keane MP; Belperio JA; Moore TA; Moore BB; Arenberg DA; Smith RE; Burdick MD; Kunkel SL; Strieter RM
    J Immunol; 1999 May; 162(9):5511-8. PubMed ID: 10228032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel combination of collagen dynamics analysis and transcriptional profiling reveals fibrosis-relevant genes and pathways.
    Blaauboer ME; Emson CL; Verschuren L; van Erk M; Turner SM; Everts V; Hanemaaijer R; Stoop R
    Matrix Biol; 2013; 32(7-8):424-31. PubMed ID: 23648810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-Jun N-terminal kinase 1 is required for the development of pulmonary fibrosis.
    Alcorn JF; van der Velden J; Brown AL; McElhinney B; Irvin CG; Janssen-Heininger YM
    Am J Respir Cell Mol Biol; 2009 Apr; 40(4):422-32. PubMed ID: 18836136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heparin attenuates bleomycin but not silica-induced pulmonary fibrosis in mice: possible relationship with involvement of myofibroblasts in bleomycin, and fibroblasts in silica-induced fibrosis.
    Piguet PF; Van GY; Guo J
    Int J Exp Pathol; 1996 Aug; 77(4):155-61. PubMed ID: 8943733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of mesenchymal stromal cells' chemotactic effect to ameliorate paraquat-induced pulmonary fibrosis.
    Zhang H; Xiao B; Jiang L; Yao W; Shen H; Xiang X
    Toxicol Lett; 2019 Jun; 307():1-10. PubMed ID: 30658152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel and extensive aspects of paraquat-induced pulmonary fibrogenesis: comparative and time-course microarray analyses in fibrogenic and non-fibrogenic rats.
    Satomi Y; Sakaguchi K; Kasahara Y; Akahori F
    J Toxicol Sci; 2007 Dec; 32(5):529-53. PubMed ID: 18198484
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of rapamycin against paraquat-induced pulmonary fibrosis in mice.
    Shao X; Li M; Luo C; Wang YY; Lu YY; Feng S; Li H; Lang XB; Wang YC; Lin C; Shen XJ; Zhou Q; Jiang H; Chen JH
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):52-61. PubMed ID: 25559956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analyses of miRNA and proteomics identify potential biological pathways associated with onset of pulmonary fibrosis in the bleomycin rat model.
    Fukunaga S; Kakehashi A; Sumida K; Kushida M; Asano H; Gi M; Wanibuchi H
    Toxicol Appl Pharmacol; 2015 Aug; 286(3):188-97. PubMed ID: 25933445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis.
    Lucey EC; Ngo HQ; Agarwal A; Smith BD; Snider GL; Goldstein RH
    Lab Invest; 1996 Jan; 74(1):12-20. PubMed ID: 8569173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure.
    Wang X; Xu D; Liao Y; Zhong S; Song H; Sun B; Zhou BP; Deng J; Han B
    Oncotarget; 2015 Nov; 6(37):39578-93. PubMed ID: 26447616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
    Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
    J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting protease activated receptor-1 with P1pal-12 limits bleomycin-induced pulmonary fibrosis.
    Lin C; Duitman J; Daalhuisen J; Ten Brink M; von der Thüsen J; van der Poll T; Borensztajn K; Spek CA
    Thorax; 2014 Feb; 69(2):152-60. PubMed ID: 24029744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.